Search

Your search keyword '"Y. Koguchi"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Y. Koguchi" Remove constraint Author: "Y. Koguchi"
126 results on '"Y. Koguchi"'

Search Results

1. Predictors of responses to immune checkpoint blockade in advanced melanoma

2. Monitoring of radiation dose distribution utilizing RPL in glass dosimeter — Its application to radioactive emergency sensing

3. Early Treatment for Ruptured Cerebral Aneurysms

4. Endovascular Treatment for Ruptured VA Dissecting Aneurysm Involving the Origin of PICA

5. Medico-Financial Environment on Treatment for Acutely Ruptured Cerebral Aneurysms

6. Nanoscale transformation of sp2 to sp3 of graphite by slow highly charged ion irradiation

7. Modification of highly oriented pyrolytic graphite (HOPG) surfaces with highly charged ion (HCI) irradiation

8. Early safety, immune monitoring, and efficacy results from three patients enrolled in a Phase 2 trial of TGFÃŽÂ 2 RI inhibitor, LY2157299, with neoadjuvant 5-fluorouracil and radiation in patients with locally advanced rectal cancer

9. Germinal center reaction (PP-031)

10. Creation of nanodiamonds by single impacts of highly charged ions upon graphite

11. Helium cryopumping system in the tandem mirror GAMMA 10

12. Nanoscale featuring of graphite surface by highly charged ion impact

13. Clearance of Subarachnoid Clots after GDC Embolization for Acutely Ruptured Cerebral Aneurysm: Comparison with Early Direct Surgery

14. Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor

15. Endovascular Treatment with GDC for Severe Acute SAH: Comparison with Early Direct Surgery

16. Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093

17. [Fulminant cerebello-brainstem encephalitis with polyradiculitis following probable Epstein-Barr virus infection]

18. Increased CSF C4d in demyelinating neuropathy indicates the radicular involvement

19. Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy

20. Nanoscale modification of electronic states of graphite by highly charged Ar-ion irradiation

21. AN ATOM-PROBE STUDY OF PASSIVATED SURFACE OF A STAINLESS STEEL

23. High plasma BNP concentration associates with clinical outcome after mechanical thrombectomy: Post hoc analysis of SKIP.

24. Maximum Diameter of Ileocecal Lymph Nodes Measured Using Abdominal Ultrasonography Allows for the Discrimination of Yersinia pseudotuberculosis Infection from Kawasaki Disease.

25. Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites.

26. Ultra-early rt-PA administration should improve patient outcome on mechanical thrombectomy: Post hoc analysis of SKIP.

27. The impact of SAH finding on CT to the clinical outcome after mechanical thrombectomy for large vessel occlusion.

28. A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer.

29. A Novel Class of On-Treatment Cancer Immunotherapy Biomarker: Trough Levels of Antibody Therapeutics in Peripheral Blood.

30. A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeutics.

31. Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms.

32. Intraoperative Serum Catecholamine Levels in a Pregnant Woman With Pheochromocytoma Undergoing Cesarean Delivery With Combined Spinal-Epidural Anesthesia: A Case Report.

33. Intravenous Alteplase is Associated with First Pass Effect in Stent-retriever but not ADAPT Thrombectomy : Post Hoc Analysis of the SKIP Study.

34. Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.

35. Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumab.

36. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.

37. Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.

38. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.

39. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

40. A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.

41. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.

42. The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study).

43. Implementation and Validation of an Automated Flow Cytometry Analysis Pipeline for Human Immune Profiling.

44. OPTIMIZATION OF A RADIOPHOTOLUMINESCENT GLASS DOSEMETER FOR OCCUPATIONAL EYE LENS DOSIMETRY IN INTERVENTIONAL RADIOLOGY/CARDIOLOGY.

45. Note: Complementary approach for radiation dosimetry with Ag + -activated phosphate glass.

46. Predictors of responses to immune checkpoint blockade in advanced melanoma.

47. Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion.

48. DEVELOPMENT OF THE NEW GLASS BADGE.

49. A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood.

50. [Multicenter Study on Evaluation of the Entrance Skin Dose by a Direct Measurement Method in Cardiac Interventional Procedures].

Catalog

Books, media, physical & digital resources